Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 3 matching records.
3 results — page 1 of 1
- Level DNarrative ReviewEurope PMC
Stem cell-derived extracellular vesicle-based therapy for nerve injury: A review of the molecular mechanisms
Narrative Review, published in World Neurosurg X (2023) — summary generated from the PubMed abstract.
- 2023
World Neurosurg X9 citations - Level CProspective StudyPubMed
Exosomes derived from human adipose mesenchymal stem cells loaded bioengineered three-dimensional amniotic membrane-scaffold-accelerated diabetic wound healing.
Prospective Study on Diabetic Foot, Chronic Wound, published in Arch Dermatol Res (2023) — summary generated from the PubMed abstract.
- 2023
Arch Dermatol Res30 citations - Level DAnimal StudyPubMed
Neural differentiation of mouse embryonic and mesenchymal stem cells in a simple medium containing synthetic serum replacement.
Animal Study, published in J Biotechnol (2013) — summary generated from the PubMed abstract.
- 2013
J Biotechnol20 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406